Systemic antiplatelet agents and anticoagulants in eyes with branch retinal vein occlusion.
Pali P SinghDurga S BorkarCason B RobbinsJane S KimFaith BirnbaumMaria Gomez-CaraballoAkshay S ThomasSharon FekratPublished in: Therapeutic advances in ophthalmology (2021)
Although the use of systemic antiplatelet or anticoagulant agents was associated with increased prevalence of CME and foveal hemorrhage at presentation of BRVO, the use of these medications was not associated with different visual or structural outcomes at the final visit.